about
Safety of new oral anticoagulant drugs: a perspectivePatients' perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapyThe new factor Xa inhibitor: Apixaban.Oral anticoagulants and risk of nephropathy.Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Implications of new anticoagulants in primary practice.
@en
type
label
Implications of new anticoagulants in primary practice.
@en
prefLabel
Implications of new anticoagulants in primary practice.
@en
P2093
P2860
P356
P1476
Implications of new anticoagulants in primary practice.
@en
P2093
P2860
P304
P356
10.1111/IJCP.12023
P577
2013-02-01T00:00:00Z